"We are Diabetes and Endocrinology Specialists who believe in serving our patients with skill and compassion to assist in improving their health."

During the past decade, North Atlanta Endocrinology & Diabetes PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "North Atlanta Endocrinology & Diabetes PC" are "Diabetes Type 2" (1 trials), "Diabetes, Type 1" (1 trials), "Diabetes, Type 2" (1 trials), "Diabetes, Type I" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "North Atlanta Endocrinology & Diabetes PC" in a lesser frequency.

Most popular intervention types in "North Atlanta Endocrinology & Diabetes PC" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Technosphere® Insulin Inhalation Powder" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Active comparator" (1 trials), "Comparator" (1 trials) and "Technosphere Insulin" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Atlanta Endocrinology & Diabetes PC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "North Atlanta Endocrinology & Diabetes PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in North Atlanta Endocrinology & Diabetes PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Atlanta Endocrinology & Diabetes PC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".